Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is resistant to the two main first-line anti-tuberculosis drugs: rifampicin and isoniazid. It is a major threat to public health worldwide. The objective of this study was to assess the potential risk factors for multidrug-resistant tuberculosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Desissa, Fanta, Workineh, Tilaye, Beyene, Takele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879744/
https://www.ncbi.nlm.nih.gov/pubmed/29606112
http://dx.doi.org/10.1186/s12889-018-5371-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879744/
https://www.ncbi.nlm.nih.gov/pubmed/29606112
http://dx.doi.org/10.1186/s12889-018-5371-3

Ejemplares similares